ACA vs OGN · P/E 57, rev $2.88B vs P/E 3.4, rev $6.40B
Arcosa Inc (ACA) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ACA and OGN stock pages for the full models.
Not investment advice.